Plant Genotyping Equipment Market

Global Plant Genotyping Equipment Market size was valued at USD 1.5 Bn in 2024, and the total Plant Genotyping Equipment Market revenue is expected to grow by 8% from 2024 to 2032, reaching nearly USD 2.78 Bn.

Plant Genotyping Equipment Market Overview

Plant enotyping equipment consists of tools and machines used to analyze DNA variations in plants, such as SNPs and SSRs, for breeding and research. Common devices include PCR Machines, Gel electrophoresis systems, and capillary sequencers for small-scale analysis, while high-throughput technologies like SNP arrays and next-generation sequencers enable large scale genetic profiling. These instruments help identify genetic markers linked to desirable traits, supporting maker assisted selection and crop improvement.

The Plant Genotyping Equipment market is mainly driven by rising demand for High-yeild, climate-resilient crops and advancements in genomic technologies. Market demand is fueled due to precision agriculture, government funding for genomic research, and increasing implementation of marker-assisted breeding. North America currently dominates the market, attributed to strong R&D investments, presence of key players like Illumina and Thermo Fisher, and widespread implementation of next generation sequencing systems, leading because of their ability to offer high throughput, cost effective genotyping, making them indispensable for lage scale crop improvement programs.

For instance, new developments, including Oxford Nanopore’s handheld sequencers, are helping Kenyan farmers cut maize breeding cycles from 5 years to 18 months. In response, Thermo Fisher slashed Ion Torrent prices 30%, triggering a price war. Meanwhile, a $70M counterfeit ring in Singapore was busted for selling fake Illumina flow cells, which disrupted cassava research in Africa. Despite this challenge these hurdles, the market is expected to hold the largest market share due to Mas, precision farming, and strong investment in genomics.To know about the Research Methodology :- Request Free Sample Report

The Plant Genotyping equipment market competitive landscape is marked by technological innovations, with Illumina dominating the sequencing segment through platforms such as NovaSeq and iSeq, favored for their accuracy and scalability. Meanwhile, Thermo Fisher leverages Ion GeneStudio S5 and quantitative PCR systems to cater to mid scle breeding programs. A key Plant Genotyping market trend is the shift towards automated, portable genotyping solutions, accelerating field to lab workflows. Plant breeding applications hold the largest market share, as breeders increasingly rely on genotyping to develop stress-tolerant and high nutrient crops.

However, challenges including high equipment cost and trade tariffs on semiconductor components, i.e, critical for sequencing machines, have disrupted supply chains, as seen during the 2023 chips shortage, which delayed shipments for major players. Recent plant Genotyping equipment industry dynamics also highlight emerging markets in Asia Pacific, where governments are investing in agricultural biotechnology, creating new market opportunities. For businesses eyeing market entry strategic partnership with Agri-tech startups and localized manufacturing is key to navigating supply-demand fluctuation and tariff impacts.

Global Plant Genotyping Equipment Market Dynamics:

Surging Demand for Climate-Resilient Crops, enhanced by Population Growth and Food Security Needs, to boost Plant Genotyping Equipment Market Growth

The Exponential growth in global population is creating unprecedented demand for high-yielding and stress-tolerant crop varieties. This demand is further amplified by climate change-induced challenges, comprising rising drought, floods, and pest outbreaks such as fall armyworm, wheat rust. The agriculture sector is rapidly implementing advanced genotyping technologies for precision and maker-assisted selection to address these pressing needs. For instance, leading seed companies and research institutions are rising implementing high-throughput sequencers, including Illumina’s NovaSeq and PacBio’s Revio systems to accelerate trait discovery and crop improvement programs. For maker-assisted selection workflows, qpCR and KASP genotyping systems from major manufacturers like Bio-Rad and Thermo Fisher Scientific are seeing strong implementation because of their accuracy and efficiency, and high-volume screening applications.

Technological Advancements and Cost Reduction to Boost Plant Genotyping Equipment Market Growth

Accelerating the development of genotyping technologies, namely next-generation sequencing and hand-held, high-throughput platforms, reduces cost and improves efficiency. Oxford Nanopore’s MinION is being used in field genotyping in Africa. Automation and artificially intelligent data analysis are increasingly simplifying workflows, decreasing labor inputs, and improving scalability. Through automation, Thermo Fisher’s Kingfisher systems reduced DNA Extraction time by 80%. In addition, government-sponsored programs and public-private partnerships are reducing barriers to entry, making broader application throughout academic, commercial, and small-scale agriculture viable.

For Instance, China’s 14th Five-Year Plan (2021-2025) allocated $500 million for seed industry modernization. This intersection of innovation and affordability is pushing the Plant Genotyping Equipment market Expansion.

However, the plant genotyping equipment industry faces several restraints including a critical shortage of skilled personnel for genomic data analysis, specifically in evolving markets. Stringent GMO regulations and intellectual property challenges, such as those seen with CRISPR-Cas9 licensing. Significant data management hurdles because of massive volumes of genomics generated, and limited awareness and accessibility among smallholder farmers who constitute 60% of global agriculture. These barriers collectively constrain Plant Genotyping equipment development and growth. Specifically in developing regions like Africa and South Asia, despite the rising genotyping equipment solutions.

Private Investments and Emerging Agri-Tech Hubs Create Market Opportunities for Plant Genotyping Equipment

The Plant Genotyping equipment markets opportunities, including high-growth evolving technologies, where rising private-sector investments by global seed giants and agri-tech startups are driving plant genotyping equipment industry demand for affordable genotype solutions. Fueling orders for industrial-scale equipment such as Illumina Novaseq X sequencers and Hamilton’s STARIet automated liquid handlers, specifically in evolving agricultural hubs like Brazil and India. Evolving Markets in Africa, Southeast Asia, and Latin America are creating strong demand for portable, ruggedized solutions like Oxford Nanopore’s MinION sequencers and LGC Biosearch’s FIELDkits that operate in field conditions with minimal infrastructure.

In addition, the emergent specialty crop industry, such as superfoods quinoa, avocados, and medical cannabis, and the organic farming revolution, and opening up niche markets for tailored genotyping services. The direct-to-consumer genetic testing trends now extending to home gardening and urban agriculture represent a revolutionary B2C revenue stream, which impacts the growth in Compact desktop sequencers and DIY genotyping kits.

In evolving markets like Kenya, the plant genotyping equipment market is developing because of private sector investments from seed multinationals. For instance, Syngenta’s collaboration with the Kenya Agricultural and Livestock Research Organization uses high-throughput genotyping to develop drought-tolerant hybrid maize varieties, addressing climate challenges in East Africa. This initiative aligns with the African Union’s 2030 seed sector transformation goals, demonstrating how commercial demand, not just government or tech drivers, fuels geotyping implementation in developing economies.

Plant Genotyping Equipment Market Recent Trends

Global Plant Genotyping Equipment Market Segment Analysis

Based on Technology Outlook, the market is segmented into SNP Genotyping, SSR Genotyping, Next-Generation Sequencing, and DNA Microarrays. The Next Generation Sequencing Segment is expected to dominate the market in 2024 and is expected to hold the largest market share over the forecast period. Next Generation Sequencing Technology led in plant genotyping equipment market due to its cost-effectiveness, high-throughput capacity, and extensive use in agricultural genomics. Its efficacy over conventional technologies, such as SSR genotyping and microarray, for identifying genetic variants important for precision agriculture. Next Generation Sequencing was given the highest priority by the U.S. department of Agriculture for massive crop improvement schemes, particularly through its agricultural genome-to-phenome programs. In 2024, AG2PI supported several projects utilizing Illumina NovaSeq and PacBio HIFI sequencing to genotype thousands of maize and wheat varieties for drought tolerance.

This initiative enabled researchers to identify key genetic markers faster and more accurately than traditional SSR or microarray methods. Next Generation Sequencing based genotyping reduces breeding cycle by 30%, providing its efficiency in developing climate-resilient crops. Bayer alone purchased 50+ Next Generation Sequencing systems in 2024 for global breeding stations.Industry leaders accelerated Next Generation Sequencing implementation with Illumina’s AgriSeq Panels, enabling Bayer’s high-throughput soybean and canola genotyping.

Breakthroughs like CRISPR-edited wheat and the African orphan crops consortium’s pangenome project underscore Next Generation Sequencing's transformative impact, while innovations like NASA’s use of portable Min ION sequencers for space-grown plants highlight its versatility. Innovations like Oxford Nanopore's Flongle made field genotyping more accessible. Although SNP arrays and QPCR retained niche roles for targeted studies, Next Generation Sequencing scalability, comprehensive data output, and integration into global crop improvement initiatives enhance its leadership in the plant genotyping equipment market.
Based on the End User, the market is segmented into. Research Institutions, Agricultural Biotechnology Companies, and Government Agencies. The Agricultural Biotechnology Companies Segment is expected to dominate the market in 2024 and is expected to hold the largest market share over the forecast period. Agricultural biotechnology companies dominate the plant genotyping equipment market as end users, driven by their large-scale implementation of high-throughput technologies like NGS and SNP arrays for commercial crop breeding programs. These companies accounted for around 45% of equipment purchases, leveraging tools such as Illumina’s Nova Seq and Thermo Fisher’s Ion Gene Studio to accelerate trait development in major crops like Syngenta, Bayer, and Corteva invested heavily in genotyping equipment to meet increasing demand for drought-resistant and high-yield varieties. Private sector R&D spending on precision breeding tools grew by 18% YOY, further solidifying biotech Firms' leadership. Agribiotech companies prioritized scalable, automated NGS systems, a trend reinforced by Illumina’s cited a 30% increase in AgriSeq panel sales to agribusinesses.

For Instance, Bayer disclosed $200 million investments in Illumina Novaseq and Thermo Fischer Ion GeneStudio Systems to scale genotyping for soybean and canola breeding. Which cited Bayer’s implementation of Next Generation Sequencing Equipment as a key competitive edge over smaller rivals still relying on SNP arrays. Orteva Agriscience announced a partnership with Thermo Fisher to deploy Ion GeneStudio s5 systems across its global breeding programs, targeting yield optimization in Maize.

This investment outpaced public sector implementation, and an 18% YOY increase in private R&D spending on precision breeding tools, further underscoring agribiotech firms' leadership in the plant genotyping equipment industry.

Plant Genotyping Equipment Market Regional Insights

The extensive adoption of innovative technologies and strong support of corporate R&D and government investments reflect North America's Dominance in the market for plant genotyping equipment. Top players, including Illumina and Thermo Fisher Scientific, have constructed sophisticated platforms like the Infinium XT Assay and Axiom Genotyping solutions that are designed with high throughput capabilities for plant as well as farm research.

These technologies are extensively used by large U.S seed corporations, including Corteva Agri science and Benson Hill Biosystems, to speed up crop trait testing and enhance soybean and corn breeding. Government agencies also support these trends. For example, the USFDA Agricultural Research Services uses LGC Bioresearch Technologies' SNPline systems to improve wheat and barley disease resistance.

In Canada, research collaborations such as Genome Alberta use Fluidigm's EP1 systems within canola breeding programs, a testament to the region's team-based efforts at developing agricultural biotechnology. The Plant Genotyping Equipment Market's strength is further evidenced by North America’s significant share of 45% of global plant genotyping equipment sales. Federal investment, such as the $32 million allocation in 2023 for upgrading lab equipment containing SNPline systems, reinforces this growth trajectory.

Academic institutions like UC Davis and Cornell University contribute substantially, operating over 300 genotyping workstations and processing more than 1.2 million plant samples annually. Moreover, the presence of advanced phenotyping-greenhouse complexes, such as Bayer’s facility in Marion, Iowa, enhances demand for integrated genotyping tools used in precision breeding. With 70% of the world’s major agri-genomics firms headquartered in North America, the region continues to lead innovations, deployment, and expansion in the plant genotyping equipment market.

Plant Genotyping Equipment Market Competitive Landscape

Illumina and Thermo Fisher Scientific dominate the plant genotyping equipment market, each with distinct strengths. Illumina leads in high throughput sequencing and array-based genotyping, with its InfiniumXT assay processing over 2.5 million plant samples annually. The company holds around 35% of the global plant genotyping equipment market share, driven by its proprietary BeadArray technology, which offers unmatched accuracy for SNP analysis. Illumina’s partnership with agribusiness giants such as Corteva and Bayer reinforces its dominance in crop genomics, specifically for large scale breeding programs. However, its systems are often higher cost, limiting accessibility for smaller labs.Thermo Fisher Scientific competes strongly with its Axiom Genotyping solutions, which are preferred for their scalability and cost efficiency, capturing around 25% of the market. The Axiom platform supports multiplexed SNP analysis, making it ideal for soybean, corn, and wheat genomics. Unlike Illumina, Thermo Fisher delivers modular systems, allowing labs to scale operations flexibly. Its Ion GeneStudio S5 series also provides portable sequencing options, appealing to field researchers. While Illumina Excels in Ultra high throughput applications, Thermo Fisher’s broader product portfolio gives it an edge in integrated lab workflows.

Plant Genotyping Equipment Market Scope: Inquire before buying

Plant Genotyping Equipment Market by Region

North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, ASEAN, Indonesia, Philippines, Malaysia, Vietnam, Thailand, ASEAN, Rest of Asia Pacific)
Middle East & Africa (South Africa, GCC, Nigeria, Rest of ME&A)
South America (Brazil, Argentina, Rest of South America)

Plant Genotyping Equipment Market Key Players are:

1. Illumina (U.S.)
2. Thermo Fisher Scientific (U.S.)
3. LGC Biosearch Technologies (U.S.)
4. Fluidigm Corporation (U.S.)
5. Agilent Technologies (U.S.)
6. PerkinElmer (USA)
7. Bio-Rad Laboratories (USA)
1. LGC Biosearch Technologies (UK)
2. Oxford Nanopore Technologies (UK)
3. Edinburgh Genomics (UK)
4. Qiagen (Germany)
1. Novogene (China)
2. Annoroad Gene Technology (China)
3. Shimadzu Corporation (Japan)
4. Hitachi High-Tech Corporation (Japan)
5. Takara Bio Inc. (Japan)

Frequently Asked Questions

1. Which region has the largest share in the Global Plant Genotyping Equipment Market?
Ans: The North America region held the highest share in 2024.

2. What is the growth rate of the Global Plant Genotyping Equipment Market?
Ans: The Global Market is expected to grow at a CAGR of 8% during the forecast period 2025-2032.

3. What is the scope of the Global Plant Genotyping Equipment Market report?
Ans: The Global Plant Genotyping Equipment Market report helps with the PESTEL, Porter's, Recommendations for Investors and leaders, and market estimation for the forecast period.

4. Who are the key players in the Global Plant Genotyping Equipment Market?
Ans: The important key players in the Global Plant Genotyping Equipment Market are Illumina, Thermo Fisher Scientific, LGC Biosearch Technologies, Fluidigm Corporation, LGC, Biosearch Technologies, and Biosearch Technologies

5. What is the study period of this market?
Ans: The Global Plant Genotyping Equipment Market is studied from 2024 to 2032.